Case Report: Making room for radicality: balancing liver reserve and oncologic clearance in hilar cholangiocarcinoma through portal vein embolisation - Scorecard - MDSpire

Case Report: Making room for radicality: balancing liver reserve and oncologic clearance in hilar cholangiocarcinoma through portal vein embolisation

  • By

  • Elvin Jia Hong Lee

  • Zhun Shen Tan

  • Azlanudin Azman

  • Isa Azzaki Zainal

  • Muhammad Zahid Abdul Muien

  • Ian Chik

  • July 8, 2026

  • 0 min

Share

Clinical Scorecard: Case Study: Optimizing Surgical Outcomes in Hilar Cholangiocarcinoma by Balancing Liver Function and Tumor Resection through Portal Vein Embolization

At a Glance

CategoryDetail
ConditionHilar Cholangiocarcinoma
Key MechanismsPortal Vein Embolization (PVE) induces future liver remnant (FLR) hypertrophy to mitigate post-hepatectomy liver failure (PHLF).
Target PopulationPatients with Bismuth-Corlette type IIIA hilar cholangiocarcinoma and marginal FLR.
Care SettingHepatobiliary surgical centers.

Key Highlights

  • PVE successfully increased FLR from 34% to 60.5%.
  • Extended right hepatectomy was performed without PHLF.
  • The case emphasizes the importance of preoperative PVE in surgical planning.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of hilar cholangiocarcinoma is based on imaging and clinical findings.

Management

  • Preoperative PVE is recommended for patients with inadequate FLR prior to major hepatectomy.

Monitoring & Follow-up

  • Monitor liver function and FLR volume post-PVE to assess suitability for surgery.

Risks

  • Risks of PVE include potential complications related to liver function and the possibility of PHLF.

Patient & Prescribing Data

61-year-old male with Bismuth-Corlette type IIIA hilar cholangiocarcinoma.

Preoperative PVE was critical in enabling safe extended hepatectomy.

Clinical Best Practices

  • Utilize PVE to enhance FLR in patients with marginal liver reserve.
  • Conduct multidisciplinary evaluations for surgical planning in hilar cholangiocarcinoma.

Related Resources & Content

Original Source(s)

Case Report: Making room for radicality: balancing liver reserve and oncologic clearance in hilar cholangiocarcinoma through portal vein embolisation

  • by Elvin Jia Hong Lee, Zhun Shen Tan, Azlanudin Azman, Isa Azzaki Zainal, Muhammad Zahid Abdul Muien, Ian Chik

  • July 8, 2026

Related Content

The use of motion tracking technology to support an exercise intervention for children and young people with cancer: perspectives of users and healthcare professionals in the FORTEe trial

Baptist Health Cancer Care to Present Research on Precision Radiation Therapy Across Complex Cancers at ASTRO 2026

Experts across Baptist Health Herbert Wertheim Cancer Institute and Eugene M. & Christine E. Lynn Cancer Institute will present new radiation oncology research and clinical expertise at the 2026 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 26-30, 2026, in Boston.

  • by

  • July 7, 2026

  • 8 min
Coexpression of GITRL confers resistance to Treg cell-mediated immunosuppression to anti-CD19 CAR-NK cells